Lucid Diagnostics shares owned by Nantahala Capital Management
Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Nantahala Capital Management
from 13F filings
Historical chart of Nantahala Capital Management investment in Lucid Diagnostics
Tip: Access up to 7 years of quarterly data
All positions including Lucid Diagnostics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lucid Diagnostics by Nantahala Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $103k | 126k | 0.82 |
| 2024-06-30 | $104k | 126k | 0.82 |
| 2024-03-31 | $132k | 150k | 0.88 |
| 2023-12-31 | $211k | 150k | 1.41 |
| 2023-09-30 | $185k | 158k | 1.17 |
| 2023-06-30 | $277k | 199k | 1.39 |
| 2023-03-31 | $377k | 262k | 1.44 |
| 2022-12-31 | $380k | 280k | 1.36 |
| 2022-09-30 | $438k | 286k | 1.53 |
| 2022-06-30 | $698k | 309k | 2.26 |
| 2022-03-31 | $1.1M | 315k | 3.36 |
| 2021-12-31 | $2.3M | 435k | 5.37 |
More positions owned by Nantahala Capital Management
View all positions for Nantahala Capital Management